[go: up one dir, main page]

GB202016165D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB202016165D0
GB202016165D0 GBGB2016165.9A GB202016165A GB202016165D0 GB 202016165 D0 GB202016165 D0 GB 202016165D0 GB 202016165 A GB202016165 A GB 202016165A GB 202016165 D0 GB202016165 D0 GB 202016165D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2016165.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Optivalent Ltd
Original Assignee
Optivalent Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optivalent Ltd filed Critical Optivalent Ltd
Priority to GBGB2016165.9A priority Critical patent/GB202016165D0/en
Publication of GB202016165D0 publication Critical patent/GB202016165D0/en
Ceased legal-status Critical Current

Links

GBGB2016165.9A 2020-10-12 2020-10-12 Vaccine Ceased GB202016165D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2016165.9A GB202016165D0 (en) 2020-10-12 2020-10-12 Vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2016165.9A GB202016165D0 (en) 2020-10-12 2020-10-12 Vaccine

Publications (1)

Publication Number Publication Date
GB202016165D0 true GB202016165D0 (en) 2020-11-25

Family

ID=73460661

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2016165.9A Ceased GB202016165D0 (en) 2020-10-12 2020-10-12 Vaccine

Country Status (1)

Country Link
GB (1) GB202016165D0 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US486012A (en) 1892-11-08 Boat-launching carriage
WO1982001995A1 (en) 1980-12-11 1982-06-24 Merieux Inst Method for purifying polyosides of streptococcus pneumoniae and vaccine based on polyosides thus purified
WO2006110352A2 (en) 2005-04-08 2006-10-19 Wyeth Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation
WO2006110381A1 (en) 2005-04-08 2006-10-19 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
WO2008118752A2 (en) 2007-03-23 2008-10-02 Wyeth Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
WO2017013548A1 (en) 2015-07-21 2017-01-26 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US486012A (en) 1892-11-08 Boat-launching carriage
WO1982001995A1 (en) 1980-12-11 1982-06-24 Merieux Inst Method for purifying polyosides of streptococcus pneumoniae and vaccine based on polyosides thus purified
WO2006110352A2 (en) 2005-04-08 2006-10-19 Wyeth Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation
WO2006110381A1 (en) 2005-04-08 2006-10-19 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
WO2008118752A2 (en) 2007-03-23 2008-10-02 Wyeth Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
WO2017013548A1 (en) 2015-07-21 2017-01-26 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Remington's Pharmaceutical Sciences", 1990, MACK PRINTING COMPANY, pages: 1289 - 1329
JODART, WHO TECHNICAL REPORT SERIES, 2003

Similar Documents

Publication Publication Date Title
GB202010425D0 (en) Combination vaccine
GB202002166D0 (en) Vaccine
IL292272A (en) Cancer vaccine
IL288673A (en) Tgf-beta vaccine
IL304441A (en) Measles-hiv or measles-htlv vaccine
GB201910794D0 (en) Vaccine
GB201917699D0 (en) Vaccine conjugates
EP4429699A4 (en) Sars-cov-2 vaccines
GB202112149D0 (en) Shigellla vaccine
GB202207281D0 (en) Vaccine
GB202016954D0 (en) Vaccine
GB201911636D0 (en) Vaccine
GB202013262D0 (en) Vaccine Composition
GB202019916D0 (en) RNA vaccine
GB202119115D0 (en) Vaccine
GB202118110D0 (en) Vaccine
GB202114274D0 (en) SARS-CoV-2 vaccine
GB202102677D0 (en) Vaccine
GB202016165D0 (en) Vaccine
GB202014719D0 (en) Vaccine
GB202013534D0 (en) Vaccine
GB202013541D0 (en) Vaccine
GB202013253D0 (en) Vaccine
GB202009402D0 (en) Vaccine
GB202005880D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)